Invariant chain (Ii), a membrane glycoprotein, binds class II major histocompatibility complex (MHC) Class II major histocompatibility complex (MHC) glycoproteins are polymorphic af3 heterodimers that bind to the trimeric invariant chain (Ii) in the endoplasmic reticulum.
into an endosomal compartment(s) (1, 2) . Ii prevents peptides from binding to class II molecules (3) . Ectodomains of Ii generated by secretion from transfected SF9 insect cells (4) and refolding of the insoluble recombinant Ii in Escherichia coli (5) block peptide binding to class II molecules. Ii is degraded by proteases in acidic endosomal compartments (6) (7) (8) , and class II molecules are loaded with peptides produced endocytically from internalized proteins (9, 10) .
In the absence of Ii, class II molecules aggregate and associate with chaperones in the endoplasmic reticulum (11, 12) . Ii "knockout" mice exhibit decreased cell surface expression of class II molecules, deficiency in protein-antigen presentation, and decreased CD4+ T cells (13, 14) .
Some mutant cell lines express class II molecules complexed predominantly with class II-associated Ii peptides (CLIP peptides; residues 81-104, Fig. 1 ) derived from the N-terminal third of the ectodomain of Ii (15, 16) . These include cells deficient in HLA-DM, a class II-like molecule that seems to play a role in removing CLIP (17, 18) . It is not known whether Ii residues corresponding to CLIP bind in the class II peptide binding site in a3-Ii complexes, but intermediates in the in vivo proteolysis of Ii include a CLIP containing a 21-kDa fragment (LIP) that remains associated with class II molecules (6, 8, 19, 20) . This and other data (21) suggest that CLIP is generated in situ on class II molecules, implying that the a/-CLIP complexes discovered in the mutant cells could be an intermediate in the normal peptide loading process.
We find that a soluble recombinant form of the Ii ectodomain that has the native trimeric state blocks the MHC class II peptide binding site and contains an exposed and probably flexible N-terminal one third, with residues within and around the CLIP region accessible to protease. We also find that the C-terminal domain of Ii is a highly a-helical trimer able to interact with "empty" MHC class II molecules.
MATERIALS AND METHODS
Genes and Bacterial Strain. The cDNA of human Ii was obtained from Eric 0. Long (National Institute of Allergy and Infectious Diseases); and the overexpression vector pQE9 was from Qiagen (Chatsworth, CA). Three pQE9 derived plasmids were used to transform E. coli strain, XA90 (22) . A PCR product containing the entire ectodomain sequence of Ii was made with the cDNA as template and the primers 5'-CGCC-GCGAATTCAGGAGGAATTTAAAAATGCAGCAGC-AGGGCCGGCTGGACAAACTGACA and 3'-GCGCAGT-CGACTCACATGGGGACTGGGCCCAGATCCTGCTT-GGT. The insert was initially ligated into the plasmid pHN1 + (22) , and the sequence was verified. To make I72 (10 ,uM proteins in 20 mM sodium phosphate, pH 7.0).
MHC Class II Molecule-Peptide Binding. Hemagglutinin (HA) peptide fragment HA-(306-318) (PKYVKQNTLKLAT in single-letter amino acid code) was labeled with 1251 by the chloramine T method (23) . The specific activity was about 2.4 x 106 cpm/,ul. Soluble empty HLA-DR1 was produced as described (24) . Experiments were performed as described in the legends to Figs. 5 and 7, and 10-Al aliquots of each sample were analyzed by 10% native PAGE. Bound peptide was measured by autoradiography (Fuji BAS-III imaging plate/ Fuji BAS 2000 system). Concentrations of labeled peptide were electrophoresed and autoradiographed to create a standard curve. The inhibition constants, K1, of unlabeled HA-(306-318) and I72 were calculated as described (23) .
GCN4-Ii. Two oligonucleotides, 5'-CGCGCGGATCCCAG-CGTATGAAACAGATCGAAGACAAAATCGAAGAA-ATCCTGTCCAAAATCTACCACATCGAAA-3' and 5'-CGTCCAGCCGGCCCTGCTGCTGACGTTCACCGATC-AGTTTTTTGATACGAGCGATTTCTTTTCGATGTGG-TAGA-3', were mixed and annealed together by using the complementary regions at their 3' ends. Taq polymerase was used to fill in the gaps and to generate the DNA duplex encoding the whole GCN4-pII (25) . The DNA duplex was inserted into pQEI2, which expresses 158. GCN4-Ii was found in the inclusion bodies, purified in urea by Ni chelation, and refolded by dilution.
Mono Q anion-exchange column. The yield after purification was about 5 mg/liter of culture.
172 was eluted as three peaks from the Mono Q column (Fig.   2 ). SDS/PAGE of peak fractions for 172 ( Fig. 2 Inset) shows that peak 1 is composed entirely of the expected polypeptide 172, while peaks 2 and 3 have in addition to 172 increasing amounts of a shorter polypeptide labeled pI72 (for proteolyzed 172). Both proteins were analyzed by mass spectrometry and N-terminal sequencing. I72 had the expected N terminus and molecular weight; p172, a truncated 172, was determined to be Ii-(94-216) (Fig. 1) .
The number of peaks and the ratios of 172 to p172 in the three peak fractions (Fig. 2 Inset) suggested that the recombinant Ii is trimeric. This was confirmed by chemical crosslinking (see below). We conclude that peak 1 (Fig. 2) Fig. 3A ) that was found to be identical to p172 by using N-terminal sequencing and mass spectroscopy. Treatment of 194 with trypsin generated two other fragments, both starting at residue 118, 14 residues C-terminal to CLIP, and containing 8-and 23-residue deletions from the C terminus (Fig. 3B and Fig. 1 (26) .
Proteolytic products stable against further digestion, like bromelain-generated bI72 [Ii-(94-216); Fig. 3A ] and trypsingenerated TI94 [Ii-(118-193); Fig. 3B ], argue for the existence of a stable C-terminal domain and indicate that the N-terminal third of Ii, residues 57-118, and the C-terminal 23 residues are more exposed to proteases and possibly more flexible. The proteolytically sensitive N-terminal 61 amino acids (58-118) includes the entire CLIP peptide (Fig. 1) .
Ii Proteins Are Trimeric and the C-Terminal Is ae-Helical. Chemical crosslinking of full-length 172 [Ii-(72-216); peak 1, Fig. 2] , the bromelain-generated fragment bI72 [Ii-(94-216)] cleaved within CLIP (Fig. 3A) , and the shortest tryptic fragment TI94 [Ii-(118-193); Fig. 3B ] confirms that they are all trimeric (Fig. 4) . The finding that TI94 is a trimer indicates that those 76 C-terminal residues are sufficient to maintain the native oligomer.
The hydrodynamic shape of recombinant 172 was examined by both gel filtration chromatography and dynamic light scattering. Both methods indicated that the trimer, although monodispersed, behaves like a protein of twice its mass (i.e., 100 kDa). The anomalously large Stoke's radius of Ii was described earlier on detergent solubilized native Ii (27) argues that the N-terminal residues 72-118, which include all of CLIP (residues 81-104), are not part of the a-helical structure. We estimate that the a-helical content of I72 is 38% and of TI94 [Ia-(118-208)] is 54% (28) .
Recombinant Ii Inhibits Antigenic Peptide Binding to Empty HLA-DR1. Purified I72 blocked antigenic peptides from binding to soluble, empty HLA-DR1 molecules (Fig. 5) . Labeled HA-(306-318) peptide, empty HLA-DR1 (24), and 172 were incubated for 3 days at 37°C, a period long enough to reach equilibrium in loading of HA peptide to HLA-DR1. I72 inhibited peptide loading of HLA-DR1 ( HLA-DR1 (80 nM) was incubated with various concentrations of labeled HA peptide for 3 days at 37°C to reach equilibrium. In the absence of the Ii C-terminal domain (0), the equilibrium yield of bound labeled peptide was 20 nM at 400 nM total peptide. In the presence of 200 nM T194 (-), the yield of bound peptide was increased to almost 50 nM; 200 nM casein or lysozyme had no effect on peptide binding.
peptide binding. We observe that T194 appears to promote HA-(306-318) peptide binding to HLA-DR1 (Fig. 6) , while the unrelated proteins casein and lysozyme have no effect. The effect of adding T194 to HLA-DR1 and HA peptide is to increase the yield of HLA-DR1-peptide complexes at every concentration of HLA-DR1 tested (Fig. 6 ). Staphylococcus aureus endotoxin B (SEB), which specifically binds to HLA-DR1 (29) , also increased the yield of HLA-DR1-peptide complexes (data not shown). Because empty, soluble HLA-DR1 molecules are known to aggregate in the absence of bound peptide (24), T194 or SEB could increase the yield of peptide-HLA-DR1 complexes by binding to and stabilizing empty HLA-DR1 molecules that would otherwise aggregate (30) .
GCN4-Ii with a Trimeric Zipper in Place of the Transmembrane Sequence of Ii Behaves Like Other Recombinant Ii. To provide evidence that the N-terminal flexibility of recombinant Ii is not an artifact of the deletion of the N-terminal membrane anchor segment, an Ii molecule was expressed where the N-terminal membrane anchor segment was replaced by a zipper sequence that forms triple-stranded a-helical coiled coils, GCN4-pII (25) (GCN4-Ii in Fig. 1) . If the transmembrane anchor is responsible for the observation that a proteolytic intermediate of Ii containing only the N terminus of Ii is trimeric (31), GCN4-pII trimers could restrict the N termini of the Ii ectodomains in a manner analogous to the Ii transmembrane segment. Even if the actual Ii transmembrane anchor does not trimerize, the structural constraints imposed will restrict the N termini analogous to attachment to a planar membrane.
Refolded GCN4-Ii was soluble, trimeric (data not shown), and a-helical (two CD minima at 0223 = -25.4 x 10-3 and 0208 = -25.88 x 10-3 deg.cm2 dmol-1). Thermal denaturation of GCN4-Ii showed the same unfolding transition as I72 at 44°C and in the presence of 3 M urea (where 172 denatures) a second transition at 70°C similar to that of the GCN4-pII zipper (25) , suggesting that both trimerization domains were folded independently in GCN4-Ii. GCN4-Ii also bound to HLA-DR1 molecules like 172, and digestion of GCN4-Ii with bromelain produced Ii-(94-216), the same fragment produced from 172 (bI72; data not shown).
DISCUSSION
Although the evidence that CLIP as a free peptide binds in the peptide binding site of MHC class II molecules is overwhelming from both peptide substitution data and x-ray diffraction (32) (33) (34) (35) , it is not known whether CLIP while part of Ii is exposed enough to fit into that site. Data presented here on trimeric recombinant Ii molecules indicate that each CLIP is part of an unusual unfolded domain (residues 58-118) in trimeric Ii and accessible to bind in MHC class II peptide binding sites. The observation that the N-terminal domains of Ii can be proteolytically removed one at a time to yield mixed trimers of full-length Ii and Ii truncated in the middle of the CLIP region (Fig. 2) indicates that the N-terminal ectodomains behave in a structurally independent manner, in contrast to the oligomer forming C-terminal domains (Fig. 7) . Furthermore, the N-terminal domain appears highly exposed. When the Ii ectodomain is not bound to class II molecules, it is readily cleaved by proteases at residue 94 in the middle of CLIP and at residue 118 14 amino acids C-terminal to CLIP (Fig. 3) , and N-terminally truncated 172 missing 15 amino acids is fully active (Fig. 5) .
What emerges from this analysis is a picture of a trimer that is stable regardless of whether its N termini are at residues 58, 72, 94, or 118. Earlier studies of Ii bound to class II molecules show that Ii can be cleaved at 81 and 104, the ends of CLIP (as occurs in vivo), and at 90 within CLIP, in both cases yielding CLIP complexes with a number of class II alleles (21, 36, 37) . Taken together, this indicates that the entire N-terminal domain of 61 residues appears to be exposed at least every 10 residues or so (58, 72, 81, 90, 94, 104, 118), arguing for an open, probably highly flexible structure. Nuclear magnetic resonance studies also provide evidence for flexible sequences on Ii (38) . Such exposed and independently acting N termini would leave the CLIP region available to bind to MHC class II molecules as though it were a free peptide, as suggested earlier (21, 39) . Direct evidence that a cleavage site C-terminal to CLIP at residue 110 is accessible in ac3Ii complexes has recently been found (P. Cresswell, personal communication) by sequencing the trimeric K3 fragment generated by proteinase K treatment of aI3li (40) . Perhaps the 118 cleavage site observed in recombinant Ii is protected by the oligosaccharides attached at 114 and 120 in human Ii (P. Cresswell, personal communication).
Comparing our observation of a cleavage site at 94 in free Ii, in the middle of the part of CLIP seen bound to HLA-DR3 in a crystal structure (35) , and the lack of observed cleavage 216k C (21, 36, 37) suggests that Ii complexed to class II molecules protects the residue-94 cleavage site because the CLIP region of Ii is bound in the peptide binding site. The observations that CLIP both in the ectodomain of Ii studied here and as a free peptide is susceptible to proteolysis but is protected from in vitro proteolysis in HLA-DR3-Ii complexes generated in vivo (21) (21) .
The highly exposed, independent nature of the N-terminal domains does not appear to be an artifact of the deletion of the N-terminal transmembrane segment because GCN4-Ii, which has a trimeric domain in place of the transmembrane domain, behaves like I72. Evidence was also found (Fig. 6 ) that the pure, soluble C-terminal domain (118-208) interacts specifically with HLA-DR1 (Fig. 7) . This is consistent with the previous finding that the presence of the Ii C-terminal domain decreases the binding of an a-chain-specific monoclonal antibody Y-3P and the class II al domain-binding superantigen TSST-1 (39) . The interaction of the C-terminal domains with class II molecules may carry out some unknown function, such as augmenting the affinity of Ii especially to class II molecules with low affinity for CLIP (32, 33) .
